Form 4 holding
EVP, Chief Commercial Officer
HAEMONETICS CORP
- Security class
- Common Stock
- Shares / value
- 39,882
- Estimated value
- $2,247,749
- Report date
- 15 May 2026
- Price
- $56.36
- Ownership
- Direct
Roy Galvin - EVP, Chief Commercial Officer at HAEMONETICS CORP
Issuer-level insider activity
- Role
- EVP, Chief Commercial Officer
- Issuer ticker
- HAE on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Roy Galvin since 03 Aug 2025
Reported holdings for Roy Galvin in HAEMONETICS CORP
Form 4 holding
EVP, Chief Commercial Officer
HAEMONETICS CORP
- Security class
- Non-qualified Stock Option (Right to Buy)
- Shares / value
- 12,317
- Estimated value
- Report date
- 16 May 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Roy Galvin in HAEMONETICS CORP
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.